Patents by Inventor Frank Bergmann

Frank Bergmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200040392
    Abstract: The present invention relates to improving the processing rate of a sequencing reaction, for example in a nanopore sequencing reaction, by means of using improved nucleoside-tags. The tags are linked to the nucleoside phosphate via a Pictet Spengler reaction. Exemplary sequencing reactions that are improved by the present methods include nanopore-based nucleic acid sequencing-by-synthesis reactions.
    Type: Application
    Filed: October 8, 2019
    Publication date: February 6, 2020
    Inventors: Frank Bergmann, Ian Quang Chau, Peter Crisalli, Hannah Marie Kallewaard-Lum, Hannes Kuchelmeister, Sebastian Johannes Pomplun, Hasham Saqib, Christian Wellner
  • Publication number: 20190390267
    Abstract: Molecules may be analyzed (e.g., sequencing of nucleic acid molecules) by tunneling recognition at a tunneling junction. Embodiments of the present invention may allow detecting individual nucleotides and the sequencing of a nucleic acid molecule using a tunneling junction. By labeling a specific nucleotide with a moiety, tunneling junctions may generate a signal with a suitable signal-to-noise ratio. The tunneling recognition uses a tunneling current that is mostly through the moiety rather than mostly through the nucleotide or a portion of the molecule of interest. Because a single nucleotide can be detected with a signal with a suitable signal-to-noise ratio resulting from the tunneling current passing through the moiety, embodiments of the present invention may allow for fast detection of nucleotides using a tunneling current.
    Type: Application
    Filed: June 19, 2019
    Publication date: December 26, 2019
    Inventors: Yann ASTIER, Juraj TOPOLANCIK, Hannes KUCHELMEISTER, Frank BERGMANN, Dieter HEINDL, Nikolaus Klaus-Peter STEINGELE
  • Publication number: 20190002968
    Abstract: The present disclosure relates to compositions and methods based on polypeptide-tagged nucleotide, and the use of such polypeptide-tagged nucleotides in nanopore devices and methods.
    Type: Application
    Filed: August 26, 2016
    Publication date: January 3, 2019
    Inventors: Frank BERGMANN, Christoph SEIDEL, Andrew TRANS, Dmitriy GREMYACHINSKIY, Hannes KUCHELMEISTER, Lars HILLRINGHAUS
  • Publication number: 20180334661
    Abstract: Herein is reported a method for the enzymatic production of a thioester comprising incubating i) a first polypeptide comprising the amino acid sequence LPXTG (SEQ ID NO: 01, wherein X can be any amino acid residue), ii) a second polypeptide that has at its N-terminus a cysteine amino acid residue or is a cysteinyl compound, and iii) a third polypeptide with sortase A activity.
    Type: Application
    Filed: March 23, 2018
    Publication date: November 22, 2018
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Martin Schatte, Mara Boenitz-Dulat, Frank Bergmann
  • Publication number: 20180252714
    Abstract: In one aspect, the present disclosure provides a system and method for the identification and characterization of a transglutaminase. Further, the present disclosure provides transglutaminase enzymes for forming isopeptide bonds, methods of forming isopeptide bonds in the presence of transglutaminases, and substrate tags for use with transglutaminases.
    Type: Application
    Filed: May 8, 2018
    Publication date: September 6, 2018
    Inventors: Thomas Albert, Frank Bergmann, Victor Lyamichev, Jigar Patel, Michael Schraeml, Wojtek Steffen, Thomas Streidl
  • Patent number: 10041134
    Abstract: The present invention relates to a method for amplifying and detecting a target nucleic acid of HCV in a sample, wherein an amplification of the nucleic acids in said sample is carried out. This amplification involves a polymerase, primers for generating an amplicon and at least two detectable probes specific for different sequence portions of said amplicon. Detection of the obtained amplicon is brought about by detecting hybridization of the probes mentioned above to said different sequence portions of the amplicon. The invention further provides reaction mixtures and kits for amplifying and detecting a target nucleic acid of HCV involving the use of at least two detectable probes specific for different sequence portions of an amplicon.
    Type: Grant
    Filed: October 13, 2016
    Date of Patent: August 7, 2018
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Frank Bergmann, Dorothea Sizmann, Heike Zitzer
  • Patent number: 10006915
    Abstract: In one aspect, the present disclosure provides a system and method for the identification and characterization of a transglutaminase. Further, the present disclosure provides transglutaminase enzymes for forming isopeptide bonds, methods of forming isopeptide bonds in the presence of transglutaminases, and substrate tags for use with transglutaminases.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: June 26, 2018
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Thomas Albert, Frank Bergmann, Victor Lyamichev, Jigar Patel, Michael Schraeml, Wojtek Steffen, Thomas Streidl
  • Patent number: 9963737
    Abstract: The present invention relates to a method for amplifying and detecting a target nucleic acid in a sample, said target nucleic comprising subgroups with sequence variations and/or individual mutations, wherein an amplification of the nucleic acids in said sample is carried out. This amplification involves a polymerase, primers for generating an amplicon and at least two detectable probes specific for different sequence portions of said amplicon. Detection of the obtained amplicon is brought about by detecting hybridization of the probes mentioned above to said different sequence portions of the amplicon. The invention further provides reaction mixtures and kits for amplifying and detecting a target nucleic acid comprising subgroups with sequence variations and/or individual mutations involving the use of at least two detectable probes specific for different sequence portions of an amplicon.
    Type: Grant
    Filed: October 16, 2013
    Date of Patent: May 8, 2018
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Frank Bergmann, Dorothea Sizmann, Heike Zitzer
  • Publication number: 20180057811
    Abstract: Provided herein is a new class of nucleic acid tagging molecules which are essentially free of homopolymer stretches. The tagging molecules can tag a plurality of individual target molecules for detection with a high degree of accuracy. The tagging molecules can be used to tag at least 105 or 106 individual target molecules. The tagged individual target molecules can be subjected to high throughput sequence analysis.
    Type: Application
    Filed: November 3, 2017
    Publication date: March 1, 2018
    Inventors: Frank Bergmann, Bruno Frey, Dieter Heindl
  • Patent number: 9834765
    Abstract: Provided herein is a new class of nucleic acid tagging molecules which are essentially free of homopolymer stretches. The tagging molecules can tag a plurality of individual target molecules for detection with a high degree of accuracy. The tagging molecules can be used to tag at least 105 or 106 individual target molecules. The tagged individual target molecules can be subjected to high throughput sequence analysis.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: December 5, 2017
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Frank Bergmann, Bruno Frey, Dieter Heindl
  • Publication number: 20170314054
    Abstract: According to one aspect, the present disclosure provides a method of identifying a substrate of a transglutaminase using a peptide array comprising a plurality of peptides. The method includes the steps of contacting the peptides in the peptide array with the transglutaminase, allowing the transglutaminase to bind to the peptides, and identifying the substrate of the transglutaminase.
    Type: Application
    Filed: June 16, 2017
    Publication date: November 2, 2017
    Inventors: THOMAS ALBERT, FRANK BERGMANN, VICTOR LYAMICHEV, JIGAR PATEL, MICHAEL SCHRAEML, WOJTEK STEFFEN
  • Publication number: 20170292145
    Abstract: The present invention relates to new methods and uses for the qualitative and quantitative detection of microbial nucleic acids using at least a first control nucleic acid, or a first and a second control nucleic acid in different concentrations. The method is based on amplification of nucleic acids, for example the polymerase chain reaction. Further provided are kits comprising components for performing said methods and uses.
    Type: Application
    Filed: June 26, 2017
    Publication date: October 12, 2017
    Inventors: Reiner Babiel, Frank Bergmann, Dorothea Sizmann
  • Patent number: 9719133
    Abstract: The present invention relates to new methods and uses for the qualitative and quantitative detection of microbial nucleic acids using at least a first control nucleic acid, or a first and a second control nucleic acid in different concentrations. The method is based on amplification of nucleic acids, for example the polymerase chain reaction. Further provided are kits comprising components for performing said methods and uses.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: August 1, 2017
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Reiner Babiel, Frank Bergmann, Dorothea Sizmann
  • Patent number: 9611505
    Abstract: During RNA isolation carrier nucleic acids such as polyA-RNA are used in order to increase the yield of the isolated RNA. The carrier nucleic acids may lead to high molecular weight products which may interfere in subsequent steps, such as reverse transcription, PCR and gel electrophoresis. The present invention therefore refers to a method and a kit for reverse transcription and the use of a blocking nucleic acid molecule for blocking the carrier polyA-RNA.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: April 4, 2017
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Frank Bergmann, Stephanie Froehner
  • Publication number: 20170088907
    Abstract: The present invention relates to a method for amplifying and detecting a target nucleic acid of HCV in a sample, wherein an amplification of the nucleic acids in said sample is carried out. This amplification involves a polymerase, primers for generating an amplicon and at least two detectable probes specific for different sequence portions of said amplicon. Detection of the obtained amplicon is brought about by detecting hybridization of the probes mentioned above to said different sequence portions of the amplicon. The invention further provides reaction mixtures and kits for amplifying and detecting a target nucleic acid of HCV involving the use of at least two detectable probes specific for different sequence portions of an amplicon.
    Type: Application
    Filed: October 13, 2016
    Publication date: March 30, 2017
    Inventors: Frank Bergmann, Dorothea Sizmann, Heike Zitzer
  • Patent number: 9512494
    Abstract: The present invention relates to a method for amplifying and detecting a target nucleic acid of HCV in a sample, wherein an amplification of the nucleic acids in said sample is carried out. This amplification involves a polymerase, primers for generating an amplicon and at least two detectable probes specific for different sequence portions of said amplicon. Detection of the obtained amplicon is brought about by detecting hybridization of the probes mentioned above to said different sequence portions of the amplicon. The invention further provides reaction mixtures and kits for amplifying and detecting a target nucleic acid of HCV involving the use of at least two detectable probes specific for different sequence portions of an amplicon.
    Type: Grant
    Filed: October 16, 2013
    Date of Patent: December 6, 2016
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Frank Bergmann, Dorothea Sizmann, Heike Zitzer
  • Patent number: 9499573
    Abstract: The present invention relates to novel iridium-based Ir(III) luminescent complexes, conjugates comprising these complexes as a label and their application, e.g. in the electrochemiluminescence based detection of an analyte.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: November 22, 2016
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Frank Bergmann, Robert Cysewski, Luisa de Cola, Sebastian Dziadek, Jesus Miguel Fernandez Hernandez, Hans-Peter Josel, Elena Longhi, Christoph Seidel
  • Patent number: 9447476
    Abstract: The present invention is directed to improved methods for amplifying and detecting a nucleic acid target that may be present in a biological sample comprising a primer pair for generating an amplicon, wherein at least one primer is modified at the 5? terminus with a polyN sequence being non-complementary to the target sequence, and a detectable probe specific for said amplicon or a DNA binding dye. The formation of high molecular weight products during amplification is prevented or partly or completely suppressed. The invention further provides reaction mixtures and kits comprising said primers for preventing or suppressing the formation of high molecular weight products during amplification and detection of the nucleic acid target.
    Type: Grant
    Filed: October 16, 2013
    Date of Patent: September 20, 2016
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Reiner Babiel, Frank Bergmann, Dorothea Sizmann
  • Patent number: 9416150
    Abstract: The present invention relates to novel iridium-based Ir(III) luminescent complexes, conjugates comprising these complexes as a label and their application, e.g. in the electrochemiluminescence based detection of an analyte.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: August 16, 2016
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Frank Bergmann, Robert Cysewski, Luisa de Cola, Sebastian Dziadek, Jesus Miguel Fernandez Hernandez, Hans-Peter Josel, Christoph Seidel
  • Publication number: 20160230221
    Abstract: The present disclosure relates to a set of at least 100 single-stranded oligonucleotide probes directed against (or complementary to) portions of a genomic target sequence of interest. The present disclosure also relates to a method of detecting a genomic target sequence of interest using the set of oligonucleotide probes and a method of generating the set of oligonucleotide probes. Further the present disclosure relates to a kit comprising the set of oligonucleotide probes and at least one further component.
    Type: Application
    Filed: April 22, 2016
    Publication date: August 11, 2016
    Inventors: Frank Bergmann, Walter Eberle, Thomas Fischer, Herbert von der Eltz